Posted in | News | Signal Processing

New Ultra-Broadband Capacitor Series from AVX

AVX Corporation, a leading manufacturer of advanced passive components and interconnect solutions, has introduced a new ultra-broadband capacitor series.

Designed to address DC blocking from 16KHz to 40GHz, AVX's new GX03 Series Ultra-Broadband Capacitors exhibit ultra-broadband performance, extremely low insertion loss, excellent return loss and X7R characteristics. Ideal applications for the GX03 Series include: semiconductor data communications, receiver optical subassemblies, transimpedance amplifiers and test equipment.

"The GX03 Series was specifically developed to address DC blocking issues from 16KHz to 40GHz in applications that require higher voltages than are accommodated by our other broadband capacitor offerings," said Larry Eisenberger, Senior Marketing Application Engineer at AVX. "Featuring all of the key benefits for which the GX Series is known, the new, higher-voltage GX03 Series solves customer design issues and adds value to the trusted GX product family."

Rated at 50VDC from -55°C to +125°C, the new GX03 Series Ultra-Broadband Capacitors feature a 0603 case size, are completely orientation insensitive, and utilize AVX's patented, precision, thin film termination process to minimize board space requirements. Available with Ni-Sn and Ni-Au terminations, AVX's GX03 Series capacitors are compatible with a wide range of attachment processes, including wire bonding for Ni-Au terminated components.

For more information about AVX, please visit www.avx.com, call 864-967-2150, or write to One AVX Boulevard, Fountain Inn, S.C. 29644.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.